News
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
News
No rise in major hemorrhagic events with antiplatelet therapy after ICH
August 3, 2020
Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?
Opinion
Hematologic manifestations of COVID-19
July 29, 2020
Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.
Article
Endothelial injury may play a major role in COVID-19–associated coagulopathy
June 29, 2020
Dr. Alan P. Lyss reviews research suggesting endotheliopathy may be a marker of COVID-19 severity.
News
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?
May 26, 2020
“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available very rapidly.”
News
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit
May 26, 2020
Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.
News
Inflammation, thrombosis biomarkers tied to COVID-19 deaths
May 20, 2020
“Of particular interest is the finding that over three quarters of critically ill patients required a ventilator and almost one third required renal dialysis support.”
News
DOACs linked to lower fracture risk versus warfarin in AFib patients
May 20, 2020
The results suggest women may particularly benefit from DOAC use.
News
COVID-19–associated coagulopathy
May 7, 2020
Early recognition and anticoagulation is imperative to improve clinical outcomes in COVID-19–associated coagulopathies.
News
COVID-19 pulmonary severity ascribed to coagulation differences
May 6, 2020
Higher mortality risk among whites with severe COVID-19 infections may be linked to higher propensity for thromboembolism than Chinese patients.